NCT06693453 Effects of Electronic Acupuncture Combined With Dry Cupping Therapy in Treating Back Pain Due to Lumbar Spondylosis
| NCT ID | NCT06693453 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Medicine and Pharmacy at Ho Chi Minh City |
| Condition | Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 76 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2024-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 76 participants in total. It began in 2024-01-01 with a primary completion date of 2024-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if Electroacupuncture combined with Dry cupping therapy works to treat back pain due to lumbar spondylosis in the qi stagnation and blood stasis pattern. I The main questions it aims to answer are: * Does Electroacupuncture combined with Dry cupping therapy reduces pain on Visual Analog Scale (VAS) of patients suffered from back pain due to lumbar spondylosis in the qi stagnation and blood stasis pattern? * Dose Electroacupuncture combined with Dry cupping therapy improving the daily activities on Oswestry Disability index (ODI) of patients suffered from back pain due to lumbar spondylosis in the qi stagnation and blood stasis pattern? * What medical problems do participants have when taking Electroacupuncture combined with Dry cupping therapy ? Researchers will compare dry cupping to a sham dry cupping (a sham cupping device was developed by establishing a small hole to reduce the negative pressure after suction such that inner pressure could not be maintained in the cup) to see if dry cupping therapy works to treat back pain due to lumbar spondylosis in the qi stagnation and blood stasis pattern. Patients with back pain due to lumbar spondylosis in the qi stagnation and blood stasis pattern will be registered for this study. They will be treated with a combination of Electroacupuncture combined with Dry cupping therapy. The intervention period is two weeks. Electronic acupuncture will be performed once a day for 2 weeks. Dry cupping therapy will be performed every 4 days for 2 weeks. Data on the Visual Analog Scale (VAS), Oswestry Disability index (ODI), and side effects of Electroacupuncture and Dry cuppingwill be recorded before the study and weekly for 2 weeks.
Eligibility Criteria
Inclusion Criteria: * Individuals, male and female, 18-70 years of age. * Report pain intensity between 3 and 7 according to the pain numerical rating scale. * ODI disability index ≥10%. * Patients diagnosed with lower back pain due to Qi stagnation and blood stasis syndrome (diagnosed by a Traditional Medicine Doctor) with clinical signs: stabbing, fixed lower back pain, worse at night, stiffness in the lumbar region, difficulty bending forward, extending, or rotating. The tongue is dark purple, possibly with blood stasis spots, and the pulse is wiry and tight or hesitant. Exclusion Criteria: * Have previously performed cupping therapy in some body segment; * Present neurological, vestibular, visual or auditory deficits that make assessments impossible; * Being in the gestational period; * Having severe spinal disease (including fractures, tumour, inflammatory diseases, or tumours); * Have undergone previous spinal surgery; * Present with radiating or sacroiliac back pain; another rheumatic disease such as fibromyalgia,or ankylosing spondylitis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06693453 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06693453 currently recruiting?
Yes, NCT06693453 is actively recruiting participants. Contact the research team at nguyenan27011997@gmail.com for enrollment information.
Where is the NCT06693453 trial being conducted?
This trial is being conducted at Ho Chi Minh City, Vietnam.
Who is sponsoring the NCT06693453 clinical trial?
NCT06693453 is sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. The trial plans to enroll 76 participants.